As a first step in improving reproducibility, we suggest that ER negativity and/or HER2 positivity of an individual DCIS lesion is indicative of a high‐grade lesion, which may be of value in distinguishing this from low‐ and intermediate‐grade DCIS, although validation is required. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.